(Q46051896)

19 December 2017

title

Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma (English)

1 reference

19 December 2017

author name string

Shi Chen

1

1 reference

19 December 2017

Jing-Hui Hou

2

1 reference

19 December 2017

Xing-Yu Feng

3

1 reference

19 December 2017

Xiao-Shi Zhang

4

1 reference

19 December 2017

Zhi-Wei Zhou

5

1 reference

19 December 2017

Jing-Ping Yun

6

1 reference

19 December 2017

Ying-Bo Chen

7

1 reference

19 December 2017

Mu-Yan Cai

8

1 reference

19 December 2017

publication date

22 April 2013

1 reference

19 December 2017

Journal of Surgical Oncology

published in

1 reference

19 December 2017

volume

107

1 reference

19 December 2017

issue

8

1 reference

19 December 2017

page(s)

799-806

1 reference

19 December 2017

Global patterns of cancer incidence and mortality rates and trends

cites work

1 reference

Key cancer cell signal transduction pathways as therapeutic targets.

21 January 2018

1 reference

Molecularly targeted therapy for gastrointestinal cancer

21 January 2018

1 reference

Mechanism and biological significance of CD44 cleavage

21 January 2018

1 reference

CD44: from adhesion molecules to signalling regulators

21 January 2018

1 reference

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis

21 January 2018

1 reference

Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18.

21 January 2018

1 reference

Hyaluronan production increases the malignant properties of mesothelioma cells

21 January 2018

1 reference

Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys

21 January 2018

1 reference

Conserved markers of fetal pancreatic epithelium permit prospective isolation of islet progenitor cells by FACS.

21 January 2018

1 reference

Isolation of murine hair-inducing cells using the cell surface marker prominin-1/CD133.

21 January 2018

1 reference

Identification of human brain tumour initiating cells

21 January 2018

1 reference

Identification and characterization of tumorigenic liver cancer stem/progenitor cells

21 January 2018

1 reference

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

Identification and expansion of the tumorigenic lung cancer stem cell population

21 January 2018

1 reference

Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.

21 January 2018

1 reference

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

21 January 2018

1 reference

CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers

21 January 2018

1 reference

CD133 expression in different stages of gastric adenocarcinoma

21 January 2018

1 reference

Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma.

21 January 2018

1 reference

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

21 January 2018

1 reference

Tumor-initiating label-retaining cancer cells in human gastrointestinal cancers undergo asymmetric cell division

21 January 2018

1 reference

Donor-derived human bone marrow cells contribute to solid organ cancers developing after bone marrow transplantation.

21 January 2018

1 reference

Isolation of live label-retaining cells and cells undergoing asymmetric cell division via nonrandom chromosomal cosegregation from human cancers

21 January 2018

1 reference

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.

21 January 2018

1 reference

CD44v6: a potential marker of malignant transformation in intestinal metaplasia of the stomach? An immunohistochemical study using tissue microarrays.

21 January 2018

1 reference

Identification of gastric cancer stem cells using the cell surface marker CD44.

21 January 2018

1 reference

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

21 January 2018

1 reference

CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth

21 January 2018

1 reference

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

CD133 is a marker of gland-forming cells in gastric tumors and Sox17 is involved in its regulation.

21 January 2018

1 reference

Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma

21 January 2018

1 reference

CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.

21 January 2018

1 reference

CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma

21 January 2018

1 reference

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma

21 January 2018

1 reference

CD44: structure, function, and association with the malignant process.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JSO.23337

1 reference

19 December 2017

1 reference

19 December 2017